Hakuhodo and Corundum Systems Biology Partner for Innovative Deep Tech VC Seminars
In a significant step toward fostering innovation in Japan's corporate landscape, Corundum Systems Biology (CSB), a pioneer in systems biology investment, is partnering with Hakuhodo Inc., a leading marketing and innovation company. Together, they are set to co-host the upcoming sessions of the Global Deep Tech VC Seminar series. These discussions will shine a light on the practical implementations of cutting-edge research and technology in the field of health and well-being.
The collaboration aims to catalyze open innovation and drive new business creations in collaboration with major Japanese corporations. "Our partnership with Hakuhodo for this seminar series supports open innovation and new business creation at major Japanese corporations," stated Hidehiko Otake, CEO of Corundum Systems Biology. The synergy between these two organizations leverages their respective strengths: CSB's access to pioneering research from global institutions and Hakuhodo's extensive network within Japan's corporate ecosystem. This partnership is a strategic move intended to integrate Japanese companies into the global innovation framework, thus enhancing their ability to compete on the international stage.
1. From Weizmann to Impact: Translating Research into Real-World Implementation
Date: March 11, 2026
Time: 3:00 PM – 4:30 PM JST
The first of the two sessions will delve into methodologies used to turn fundamental research from the Weizmann Institute of Science into practical applications that can benefit society. This discussion will not only be led by prominent figures in research but also include insights from business leaders experienced in commercializing research outcomes. Featured speakers include Eran Segal, PhD, a professor at the Weizmann Institute, and Ori Cohen, PhD, co-founder and CEO of Pheno.AI Ltd. The discussion promises to be enriching, providing attendees with a thorough understanding of the complexities involved in bringing scientific innovations to the forefront of public health solutions.
2. Deploying Weizmann Technology in Japan: Insights from the Front Lines
Date: March 17, 2026
Time: 8:00 AM – 9:30 AM JST
The second seminar will focus on the challenges and strategies surrounding the deployment of technologies developed at the Weizmann Institute in the Japanese market. Hidehiko Otake will present insights on the importance of global collaboration within the deep tech space and the design of practical partnerships essential for penetrating the Japanese market. This session is crucial for businesses and innovators looking to understand the operational aspects of integrating international technology in local settings.
Corundum Systems Biology (CSB) stands out in the venture capital domain, focusing on transformative solutions in systems biology that promote human health. CSB's commitment extends beyond mere financial investment; it offers comprehensive support through deep domain expertise and connections across the health data spectrum. With CSB’s focus on long-term success, it’s positioned as a leader in supporting groundbreaking companies making a genuine impact. On the other hand, Hakuhodo continues to reinforce its status in integrated marketing, solidifying partnerships that enhance creativity and innovation.
For those eager to participate in these informative sessions, registration details are accessible through provided links. This collaboration between Corundum Systems Biology and Hakuhodo signifies a pivotal moment for professionals in the deep tech and investment sectors, aiming to bridge gaps, share knowledge, and stimulate innovative solutions on a global scale.
For continued updates and insights, follow Corundum Systems Biology on LinkedIn, or navigate to their official website at csb.co.jp. These seminars represent an invaluable opportunity for those involved in technology, health, and venture capital to engage with pioneering research and its far-reaching implications.
The Purpose of the Seminar Series
The collaboration aims to catalyze open innovation and drive new business creations in collaboration with major Japanese corporations. "Our partnership with Hakuhodo for this seminar series supports open innovation and new business creation at major Japanese corporations," stated Hidehiko Otake, CEO of Corundum Systems Biology. The synergy between these two organizations leverages their respective strengths: CSB's access to pioneering research from global institutions and Hakuhodo's extensive network within Japan's corporate ecosystem. This partnership is a strategic move intended to integrate Japanese companies into the global innovation framework, thus enhancing their ability to compete on the international stage.
What to Expect in the Upcoming Sessions
1. From Weizmann to Impact: Translating Research into Real-World Implementation
Date: March 11, 2026
Time: 3:00 PM – 4:30 PM JST
The first of the two sessions will delve into methodologies used to turn fundamental research from the Weizmann Institute of Science into practical applications that can benefit society. This discussion will not only be led by prominent figures in research but also include insights from business leaders experienced in commercializing research outcomes. Featured speakers include Eran Segal, PhD, a professor at the Weizmann Institute, and Ori Cohen, PhD, co-founder and CEO of Pheno.AI Ltd. The discussion promises to be enriching, providing attendees with a thorough understanding of the complexities involved in bringing scientific innovations to the forefront of public health solutions.
2. Deploying Weizmann Technology in Japan: Insights from the Front Lines
Date: March 17, 2026
Time: 8:00 AM – 9:30 AM JST
The second seminar will focus on the challenges and strategies surrounding the deployment of technologies developed at the Weizmann Institute in the Japanese market. Hidehiko Otake will present insights on the importance of global collaboration within the deep tech space and the design of practical partnerships essential for penetrating the Japanese market. This session is crucial for businesses and innovators looking to understand the operational aspects of integrating international technology in local settings.
About the Organizers
Corundum Systems Biology (CSB) stands out in the venture capital domain, focusing on transformative solutions in systems biology that promote human health. CSB's commitment extends beyond mere financial investment; it offers comprehensive support through deep domain expertise and connections across the health data spectrum. With CSB’s focus on long-term success, it’s positioned as a leader in supporting groundbreaking companies making a genuine impact. On the other hand, Hakuhodo continues to reinforce its status in integrated marketing, solidifying partnerships that enhance creativity and innovation.
Registration Information
For those eager to participate in these informative sessions, registration details are accessible through provided links. This collaboration between Corundum Systems Biology and Hakuhodo signifies a pivotal moment for professionals in the deep tech and investment sectors, aiming to bridge gaps, share knowledge, and stimulate innovative solutions on a global scale.
For continued updates and insights, follow Corundum Systems Biology on LinkedIn, or navigate to their official website at csb.co.jp. These seminars represent an invaluable opportunity for those involved in technology, health, and venture capital to engage with pioneering research and its far-reaching implications.
Topics Business Technology）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.